Emma Yasinski

Publications:

Featured Articles

Tejocote Root and the Tainted Supplement Problem the FDA Can't Contain

Tejocote Root and the Tainted Supplement Problem the FDA Can’t Contain republish) One September day in 2022, a New Jersey mother rushed her toddler to the emergency room after the little girl began vomiting. The ER team discovered that the child's blood p... See more

medshadow.org•Emma Yasinski•May 28, 2026

Entrevista con una neurocientífica que estudia lo que la adicción le hace al cerebro

“La recaída forma parte de la recuperación”: esa es una frase habitual entre los profesionales que tratan los trastornos por consumo de sustancias. Muchas personas que han completado programas de tratamiento vuelven a consumir sustancias y reingresan en e... See more

elespectador.com•Emma Yasinski•May 23, 2026

Sylvester Comprehensive Cancer Center Researcher Presents Phase 1 Trial for Neuroendocrine Tumors at ASCO

Sylvester Comprehensive Cancer Center Researcher Presents Phase 1 Trial for Neuroendocrine Tumors at ASCO Summary - A Sylvester researcher will present a phase I clinical trial combining immunotherapy and an oncolytic virus at the ASCO annual meeting. - T... See more

miami.edu•Emma Yasinski•May 21, 2026

INVESTIGATING GENERICS: Researchers Warn U.S. Can't Guarantee Safety of Generic Drugs

Even as generic drugs have saved Americans trillions of dollars since 1984, two prominent researchers argue the U.S still cannot fully guarantee the safety of its drug supply. In a March 2026 paper published in the New England Journal of Medicine, Kevin S... See more

medshadow.org•Emma Yasinski•May 19, 2026

Sylvester Researchers Receive $2.7 Million Grant to Study Stress Management for Breast Cancer Survivors

•

MedShadow

•

0 responses

HARO Queries

Women who were prescribed Makena or progesterone during pregnancy

Health and Pharma

Deadline: May 22nd, 2026 12:00 AM ET

•

MedShadow Foundation

•

0 responses

Pharmacists + Techs to Discuss Recall Process

Health and Pharma

Deadline: May 11th, 2026 12:00 AM ET

•

MedShadow Foundation

•

0 responses

People who have used tejocote supplements

Health and Pharma

Deadline: Dec 17th, 2025 12:00 AM ET

•

MedShadow

•

1 responses

healthcare providers to comment on new hot flash drug

Health and Pharma

Deadline: Nov 5th, 2025 12:00 PM ET

•

medshadow

•

3 responses

doctors and pharmacists that treat epilepsy

Health and Pharma

Deadline: Sep 10th, 2025 12:00 AM ET

•

MedShadow

•

0 responses

Emma Yasinski

Featured Articles

Tejocote Root and the Tainted Supplement Problem the FDA Can't Contain

Entrevista con una neurocientífica que estudia lo que la adicción le hace al cerebro

Sylvester Comprehensive Cancer Center Researcher Presents Phase 1 Trial for Neuroendocrine Tumors at ASCO

INVESTIGATING GENERICS: Researchers Warn U.S. Can't Guarantee Safety of Generic Drugs

Sylvester Researchers Receive $2.7 Million Grant to Study Stress Management for Breast Cancer Survivors

HARO Queries

Women who were prescribed Makena or progesterone during pregnancy

Pharmacists + Techs to Discuss Recall Process

People who have used tejocote supplements

healthcare providers to comment on new hot flash drug

doctors and pharmacists that treat epilepsy

Connect with journalists.

Connect with journalists.

Featured Articles

Tejocote Root and the Tainted Supplement Problem the FDA Can't Contain

Entrevista con una neurocientífica que estudia lo que la adicción le hace al cerebro

Sylvester Comprehensive Cancer Center Researcher Presents Phase 1 Trial for Neuroendocrine Tumors at ASCO

INVESTIGATING GENERICS: Researchers Warn U.S. Can't Guarantee Safety of Generic Drugs

Sylvester Researchers Receive $2.7 Million Grant to Study Stress Management for Breast Cancer Survivors

HARO Queries

Women who were prescribed Makena or progesterone during pregnancy

Pharmacists + Techs to Discuss Recall Process

People who have used tejocote supplements

healthcare providers to comment on new hot flash drug

doctors and pharmacists that treat epilepsy